Deliver Consulting Limited | Back to main site
Home > Forum Agenda > Program Overview

Program Overview

China and Asia over the decades has been playing an increasingly important role in the context of clinical research activities due to the significant scientific investment by multinational companies as well as rapidly booming China domestic R&D programs. In past few year, the China regulatory agency has also issued several regulations and initiatives to accelerate the review and approval and improve the quality of new drugs and medical devices. With the joining of ICH in 2017, the government is continuing to improve the regulatory standards and systems to promote innovation, enhance the R&D ecosystem. And the scale, complexity and cost of clinical trials have simultaneously and exponentially increased. However, the drug development is fraught with all kinds of challenges which needs innovation, efficiency and collaboration. With further advancement in new technologies and digital innovation, the pharma/biotech industry are also poised to capitalize on these advancements to innovate existing clinical trial processes and systems.

In return, the Clinical Development and Innovation Forum 2021 will gather leaders and scientists across pharma, biotech and academia for discussions and cases studies on the major topics including: robust Clinical and Regulatory Strategy, Clinical Biomarkers and CDx, Immuno-Oncology and Cell & Gene Therapies, Rare Disease, Data Sciences and Digital Innovation, AI and Machine Learning, China Domestic R&D Innovation, Patient Strategies etc. 
Overall, the forum aims to provide an opportunity for networking and building partnerships to accelerate the Efficient and GCP-compliant Drug Development in the era of Precision Medicine.

Conference Topics include:

Session 1: Clinical and Regulatory Strategy, Next Generation Clinical Trials
Session 2: Clinical Development for Biologics, Oncolytic Virus Therapy, Cell and Gene Therapies
Session 3: Clinical Biomarkers and Companion Diagnostics
Session 4: Early Clinical Development and Precision Oncology Trials
Session 5: China-initiated New Drug Development: Opportunities and Challenges
Session 6: Clinical Data Management, Biostatistics and Virtual Trials
Session 7: Clinical Safety and Pharmacovigilance
Sesison 8: Big Data Analytics, AI and Machine Learning in Clinical Development
Session 9: Clinical Operation, Quality and Supply Management
Session 10: Clinical Outsourcing and Vendor Management

Currently we are receiving the podium/poster abstracts. If you are working in the above areas, you are invited to submit a proposal. For more information, please contact

Wei Zhang
Program Manager
Organizing Committee
Phone: +86-21-6034-0229